Arq (ARQ) vs ASP Isotopes (ASPI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Arq (ARQ) has outperformed ASP Isotopes (ASPI) over the past year, losing 19.4% versus a loss of 81.6%. ASP Isotopes is the larger company by market cap ($171.4 million vs $124.6 million), about 1.4 times the size. Arq converts more of its revenue into profit, with a net margin of -43.7% versus -670.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARQ | ASPI |
|---|---|---|
| Share price | $2.82 | $1.10 |
| Market cap | $124.61M | $171.42M |
| 1-day change | -3.42% | -3.08% |
| YTD return | -13.76% | -79.44% |
| 1-year return | -19.43% | -81.57% |
| 5-year return | -57.34% | — |
| Forward P/E | 188.00 | — |
| EPS (TTM) | $-1.20 | $-1.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $120.34M | $23.85M |
| Revenue growth (YoY) | +10.44% | +475.51% |
| Net income (latest FY) | $-52.61M | $-159.84M |
| Gross margin | 27.87% | 14.28% |
| Operating margin | -44.01% | -251.20% |
| Net margin | -43.72% | -670.23% |
| 52-week high | $4.02 | $8.60 |
| 52-week low | $1.54 | $1.03 |
| Distance from 52-week high | -29.85% | -87.21% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +50.71% | +1081.82% |
| Average volume | 494.33K | 4.45M |
| Shares outstanding | 44.19M | 155.83M |
| Employees | 201 | 271 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARQ has outperformed ASPI by 62.1 percentage points over the past year.
- Arq is more profitable, keeping -43.7 cents of every revenue dollar as net income versus -670.2 cents for ASP Isotopes.
- ASP Isotopes grew revenue faster in its latest fiscal year (+475.51% vs +10.44%).
About Arq
ARQ stock →Arq, Inc., an environmental technology company, engages in the sale of consumable air, water, and soil treatment solutions based on activated carbon in the United States and Canada. Its products include granular activated carbon, powdered activated carbon, and colloidal carbon products; and additives for air emissions control.
Industrials · Major Chemicals · 201 employees
About ASP Isotopes
ASPI stock →ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services.
Industrials · Major Chemicals · 271 employees
ARQ vs ASPI FAQ
Which is bigger, Arq or ASP Isotopes?
ASP Isotopes (ASPI) is larger, with a market capitalization of $171.42M compared with $124.61M for Arq (ARQ).
Which stock has performed better over the past year, ARQ or ASPI?
ARQ returned -19.43% over the past 12 months, compared with -81.57% for ASPI (price return, excluding dividends). Past performance does not predict future results.
Are Arq and ASP Isotopes in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.